Cargando…

Effects of 3-year GH replacement therapy on bone mineral density in younger and elderly adults with adult-onset GH deficiency

OBJECTIVE: Little is known of the effects of long-term GH replacement on bone mineral content (BMC) and bone mineral density (BMD) in elderly GH-deficient (GHD) adults. DESIGN/PATIENTS/METHODS: In this prospective, single-center, open-label study, the effects of 3-year GH replacement were determined...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elbornsson, Mariam, Götherström, Galina, Franco, Celina, Bengtsson, Bengt-Åke, Johannsson, Gudmundur, Svensson, Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioScientifica 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261573/ https://www.ncbi.nlm.nih.gov/pubmed/22106341 http://dx.doi.org/10.1530/EJE-11-0886

Ejemplares similares

Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency
por: Elbornsson, Mariam, et al.
Publicado: (2012)

Fifteen years of GH replacement improves body composition and cardiovascular risk factors
por: Elbornsson, Mariam, et al.
Publicado: (2013)

GH deficiency and insensitivity in children and adults
por: Johannsson, Gudmundur, et al.
Publicado: (2021)

Is GH Replacement for Adult GH Deficiency Safe?
por: Melmed, Shlomo
Publicado: (2022)

Extracellular Water and Blood Pressure in Adults with Growth Hormone (GH) Deficiency: A Genotype-Phenotype Association Study
por: Barbosa, Edna J. L., et al.
Publicado: (2014)

A Case With Adult GH Deficiency Complicated With Osteogenesis Imperfecta: Effect of GH Replacement on Bone Mineral Density
por: Taguchi, Tomomi, et al.
Publicado: (2021)

Early versus late initiation of GH replacement in adult-onset hypopituitarism
por: Postma, Mark R, et al.
Publicado: (2020)

Dose–exposure–IGF-I response of once-weekly somapacitan in adults with GH deficiency
por: Kildemoes, Rasmus Juul, et al.
Publicado: (2022)

Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors—a review of research and clinical practice
por: Boguszewski, Margaret C. S., et al.
Publicado: (2021)

Impact of Growth Hormone (GH) Deficiency and GH Replacement upon Thymus Function in Adult Patients
por: Morrhaye, Gabriel, et al.
Publicado: (2009)

Childhood-Onset GH Deficiency versus Adult-Onset GH Deficiency: Relevant Differences Regarding Insulin Sensitivity
por: Garmes, Heraldo Mendes, et al.
Publicado: (2022)

GH Replacement in the Elderly: Is It Worth It?
por: Ricci Bitti, Silvia, et al.
Publicado: (2021)

GH and Senescence: A New Understanding of Adult GH Action
por: Chesnokova, Vera, et al.
Publicado: (2021)

Metabolomics: a tool for the diagnosis of GH deficiency and for monitoring GH replacement?
por: Höybye, Charlotte, et al.
Publicado: (2014)

Update on GH therapy in adults
por: Boguszewski, Cesar Luiz
Publicado: (2017)

Accuracy and Limitations of the Growth Hormone (GH) Releasing Hormone-Arginine Retesting in Young Adults With Childhood-Onset GH Deficiency
por: Patti, Giuseppa, et al.
Publicado: (2019)

The prevalence of the metabolic syndrome and associated cardiovascular complications in adult-onset GHD during GH replacement: a KIMS analysis
por: Verhelst, Johan, et al.
Publicado: (2018)

Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial
por: Johannsson, Gudmundur, et al.
Publicado: (2020)

GH deficiency status combined with GH receptor polymorphism affects response to GH in children
por: Valsesia, Armand, et al.
Publicado: (2015)

Early Onset GH Excess: Somatotroph Adenoma in a Young Adult
por: Galbiati, Francesca, et al.
Publicado: (2023)

GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults
por: Allen, D B, et al.
Publicado: (2015)

Regulation of GH and GH Signaling by Nutrients
por: Caputo, Marina, et al.
Publicado: (2021)

Growth Hormone Research Society perspective on biomarkers of GH action in children and adults
por: Johannsson, Gudmundur, et al.
Publicado: (2018)

No Improvement of Adult Height in Non-growth Hormone (GH) Deficient Short Children with GH Treatment
por: Tanaka, Toshiaki, et al.
Publicado: (2006)

Prospective Safety Surveillance of GH-Deficient Adults: Comparison of GH-Treated vs Untreated Patients
por: Hartman, Mark L., et al.
Publicado: (2013)

Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients
por: Johannsson, Gudmundur, et al.
Publicado: (2022)

Favorable Impacts of Growth Hormone (GH) Replacement Therapy on Atherogenic Risks in Japanese Children with GH Deficiency
por: Kohno, Hitoshi, et al.
Publicado: (2012)

GH deficiency in patients with spinal cord injury: efficacy/safety of GH replacement, a pilot study
por: Cuatrecasas, Guillem, et al.
Publicado: (2018)

Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trial
por: Johannsson, Gudmundur, et al.
Publicado: (2018)

Lack of regulation of 11β-hydroxysteroid dehydrogenase type 1 during short-term manipulation of GH in patients with hypopituitarism
por: Sigurjonsdottir, Helga A, et al.
Publicado: (2009)

Prevalence of growth hormone (GH) deficiency in previously GH‐treated young adults with Prader‐Willi syndrome
por: Donze, Stephany H., et al.
Publicado: (2019)

Growth hormone (GH) replacement in hypopituitary adults with GH deficiency evaluated by a utility-weighted quality of life index: a precursor to cost–utility analysis
por: Kołtowska-Häggström, Maria, et al.
Publicado: (2008)

Three-Year Follow-up Study on Serum Leptin Levels in GH Deficient Children with GH Replacement Therapy
por: Kishi, Megumi, et al.
Publicado: (2006)

Diagnosis of GH Deficiency Without GH Stimulation Tests
por: Ibba, Anastasia, et al.
Publicado: (2022)

GH Supplementation Effects on Cardiovascular Risk in GH Deficient Adult Patients: A Systematic Review and Meta-analysis
por: Giagulli, Vito A., et al.
Publicado: (2017)

Growth Hormone (GH) Treatment Decreases Plasma Kisspeptin Levels in GH-Deficient Adults with Prader–Willi Syndrome
por: Giménez-Palop, Olga, et al.
Publicado: (2021)

Immobilization of Glycoside Hydrolase Families GH1, GH13, and GH70: State of the Art and Perspectives
por: Graebin, Natália G., et al.
Publicado: (2016)

Thyroid function in children with growth hormone (GH) deficiency during the initial phase of GH replacement therapy - clinical implications
por: Smyczynska, Joanna, et al.
Publicado: (2010)

Growth Hormone (GH) Hypersecretion and GH Receptor Resistance in Streptozotocin Diabetic Mice in Response to a GH Secretagogue
por: Johansen, Peter B., et al.
Publicado: (2003)

Functional analysis of GhCHS, GhANR and GhLAR in colored fiber formation of Gossypium hirsutum L
por: Gao, Jianfang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vd22mn9pkvdb914v2jb6cutj1l